治療方法としてキメラ (PhosTACs) を標的とする酸化によるタウの標的型脱酸化
Zhenyi Hu1, Po-Han Chen1,2,3, Wenxue Li4
1Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut 06511, United States.
Journal of the American Chemical Society
|February 8, 2023
まとめ
新しいPhosTAC技術は,タウをネイティブ・フォスファターゼに誘導することで,タウのリン酸化を効果的に減少させます. このアプローチは アルツハイマー病や他のタオパシーに対する 治療戦略として有望です
科学分野:
- 神経科学
- 生物化学
- 薬理学について
背景:
- 微小管に関連したタンパク質tau (tau) は微小管の安定性にとって極めて重要です.
- ハイパーリン酸化タウはアルツハイマー病とタウ病の特徴です.
- タウ酸化を抑制する既存のキナーゼ阻害剤の戦略は,限られた治療効果を示している.
研究 の 目的:
- 標的型タウ脱リン酸化のための小分子ベースのリン酸化標的キメラ (PhosTACs) の開発と評価.
- タウをPP2Aフォスファターゼに誘導するPhosTACの有効性を調査する.
- タオパシーに対する PhosTAC技術の治療の可能性を評価する.
主な方法:
- 小分子ベースのPhosTACの開発
- タウの脱リン酸化を評価するインビトロとインビボの研究
- タウ酸化部位の変化を検証する質量スペクトロメトリー
- タウタンパク質のダウンレギュレーションと三元複合体の形成の分析
主要な成果:
- PhosTACsは,安定した三重複合体を形成して,PP2Aフォスファターゼにタウを成功裏に勧誘した.
- 迅速で効率的で持続的なタウの脱酸化が観察されました.
- PhosTAC治療は,総タウタンパク質のダウンレギュレーションを強めた.
- マススペクトロメトリーは 多数のタウリン酸化部位のダウンレギュレーションを確認した.
結論:
- PhosTAC技術は,タウの脱リン酸化を誘導するための新しい効果的な方法を提供します.
- このアプローチは,タウ酸化を調節する現在の戦略に優れている.
- PhosTACsは,タオパシーに対する病気を改変する治療法の有望な新しい道を示しています.
関連する概念動画
01:02Phosphorylation
50.8K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
50.8K
01:22Alzheimer's Disease: Treatment
237
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
237
02:54Protein Kinases and Phosphatases
13.3K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.3K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K